Objetivo
Degenerative disorders of the nervous system including Alzheimer's, Parkinson's, Huntington's, motor neuron and prion diseases are among the most debilitating illnesses, putting an enormous strain on both social and health care budgets in Europe. As these diseases progress, all but the most primitive functions of the nervous system are lost due to the degeneration and subsequent death of nerve cells. Eventually patients die in a state of incapacitation. Only a small fraction of cases can be accounted for by gene mutations. Altogether, the underlying aetiologies are poorly understood. A hallmark common to these neurodegenerative disorders is the deposition of abnormal protein aggregates. There is currently no treatment available that can halt or prevent, let alone reverse nerve cell degeneration. The APOPIS project is designed to apply the unique information provided by sequencing of the human genome to further the understanding of and to develop treatments for these deva¬ stating diseases. By integrating Europe's leading research centres in clinical research, human genetics, cell biology, genomics, proteomics and bioinformatics, the VERUM Foundation has devised a consortium to identify genes involved, determine their biological functions, establish their role in the patho-physiological processes and identify novel avenues for early diagnosis, treatment and prevention. The chosen approach is based on human population genetics complemented by the identification of modifier genes in model organisms that express both wildtype and mutant variants of known disease-related genes. The consortium meets the prerequisites for such a project: ground breaking research in functional genomics related to human health, creating synergies with and between national research efforts, teaming up with both small biotechnology and pharmaceutical companies for the development of diagnostic tools and new drugs, and providing training and mobility to improve the skills of...
Ámbito científico
- natural sciencesbiological sciencesneurobiology
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- medical and health sciencesbasic medicineneurologyparkinson
- medical and health sciencesbasic medicinemedical genetics
- medical and health sciencesbasic medicineneurologyamyotrophic lateral sclerosis
Palabras clave
Convocatoria de propuestas
FP6-2002-LIFESCIHEALTH
Consulte otros proyectos de esta convocatoria
Régimen de financiación
IP - Integrated ProjectCoordinador
MUENCHEN
Alemania
Ver en el mapa
Participantes (33)
ZWIJNAARDE
Ver en el mapa
ZURICH
Ver en el mapa
BASEL
Ver en el mapa
LAUSANNE
Ver en el mapa
ZURICH
Ver en el mapa
FREIBURG
Ver en el mapa
MUENCHEN
Ver en el mapa
101062 MUENCHEN
Ver en el mapa
DARMSTADT
Ver en el mapa
WUERZBURG
Ver en el mapa
BERLIN
Ver en el mapa
BARCELONA
Ver en el mapa
HEIDELBERG
Ver en el mapa
PARIS
Ver en el mapa
LILLE
Ver en el mapa
287 PARIS
Ver en el mapa
ATHENS
Ver en el mapa
JERUSALEM
Ver en el mapa
TORINO (TURIN)
Ver en el mapa
MILANO
Ver en el mapa
NAPLES
Ver en el mapa
GENOVA
Ver en el mapa
WARSZAWA
Ver en el mapa
AVEIRO
Ver en el mapa
256 UPPSALA
Ver en el mapa
117 LUND
Ver en el mapa
LONDON
Ver en el mapa
CANTERBURY
Ver en el mapa
LONDON
Ver en el mapa
CAMBRIDGE
Ver en el mapa
HAMBURG
Ver en el mapa
HEIDELBERG
Ver en el mapa
MARBURG
Ver en el mapa